151 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
152 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
153 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
154 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
155 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
156 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
157 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
158 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
159 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
160 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
161 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
162 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
163 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
164 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
165 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
166 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
167 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
168 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
169 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
170 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
171 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
172 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
173 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
174 |
NOVO NORDISK INC. et al v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-02445 |
D.N.J. |
|
|
|
|
175 |
NOVO NORDISK INC. et al v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-02445 |
D.N.J. |
|
|
|
|
176 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
177 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
178 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
179 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
180 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-00874 |
D.N.J. |
|
|
|
|
181 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
182 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
183 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
184 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
185 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
186 |
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Pharmaceuticals, Inc. et al |
1:08-cv-00101 |
N.D.W.Va. |
|
|
|
|
187 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
188 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
189 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
190 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
191 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
192 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
193 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
194 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
195 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
196 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
197 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
198 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
199 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
200 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|